HomeComparePCHUY vs JNJ

PCHUY vs JNJ: Dividend Comparison 2026

PCHUY yields 1.13% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $10.4K in total portfolio value· pulled ahead in Year 5
10 years
PCHUY
PCHUY
● Live price
1.13%
Share price
$4.88
Annual div
$0.06
5Y div CAGR
-46.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.9K
Annual income
$0.22
Full PCHUY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — PCHUY vs JNJ

📍 JNJ pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPCHUYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PCHUY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PCHUY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCHUY
Annual income on $10K today (after 15% tax)
$96.31/yr
After 10yr DRIP, annual income (after tax)
$0.19/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,985.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCHUY + JNJ for your $10,000?

PCHUY: 50%JNJ: 50%
100% JNJ50/50100% PCHUY
Portfolio after 10yr
$25.1K
Annual income
$2,344.81/yr
Blended yield
9.35%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PCHUY
No analyst data
Altman Z
1.4
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCHUY buys
0
JNJ buys
0
No recent congressional trades found for PCHUY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPCHUYJNJ
Forward yield1.13%2.13%
Annual dividend / share$0.06$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-46.5%28%
Portfolio after 10y$19.9K$30.3K
Annual income after 10y$0.22$4,689.40
Total dividends collected$131.00$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PCHUY vs JNJ ($10,000, DRIP)

YearPCHUY PortfolioPCHUY Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,761$60.62$10,592$272.30+$169.00PCHUY
2$11,546$32.61$11,289$357.73+$257.00PCHUY
3$12,372$17.50$12,123$472.89+$249.00PCHUY
4$13,248$9.37$13,141$629.86+$107.00PCHUY
5← crossover$14,180$5.02$14,408$846.81$228.00JNJ
6$15,175$2.69$16,021$1,151.60$846.00JNJ
7$16,239$1.44$18,122$1,588.22$1.9KJNJ
8$17,377$0.77$20,930$2,228.20$3.6KJNJ
9$18,593$0.41$24,792$3,191.91$6.2KJNJ
10$19,895$0.22$30,274$4,689.40$10.4KJNJ

PCHUY vs JNJ: Complete Analysis 2026

PCHUYStock

PTT Public Company Limited, together with its subsidiaries, operates as a petroleum and petrochemical company in Thailand, other Asian countries, Europe, the United States, and internationally. It operates through Upstream Petroleum and Natural Gas Business Group, Downstream Petroleum Business Group, and New Business and Infrastructure Group. The company is involved in the exploration and production of petroleum; and natural gas procurement, pipeline transmission, distribution, and separation activities. In addition, it engages in the exploration, production, and distribution of coal; and marketing of petroleum products and lube oil through an operating system of procurement, storage, and distribution of products, as well as the retail business at service stations. Further, the company imports and exports petroleum and petrochemical products, as well as other related products; produces and distributes electricity, steam, and water for industrial purpose; and offers project management, human resource support, petroleum related technology, consultant management, technical consultant for electricity businesses, petrol station and convenience store management, factory maintenance and engineering, oil and gas, safety and environmental, and business services, as well as services for the storage and handling of liquid chemicals. Additionally, it invests in liquefied natural gas business; produces and distributes chilled water/constructs and installs electricity generating systems; develops electricity power production projects; develops, markets, and distributes polymers products, by products, and other polymers-related products; develops real estate properties; operates vocational schools; and manufactures and distributes biochemical products, paraxylene, and industrial coatings and additives, as well as engages in the transportation, warehouse, and bagging packing management of polyethylene. The company was founded in 1978 and is headquartered in Bangkok, Thailand.

Full PCHUY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this PCHUY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCHUY vs SCHDPCHUY vs JEPIPCHUY vs OPCHUY vs KOPCHUY vs MAINPCHUY vs ABBVPCHUY vs MRKPCHUY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.